Finzati - Logo
MDXG logo

MiMedx Group, Inc.

MDXG • Biotechnology
$4.57
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$675.43M
Growth
—
Cash Flow
3/5
Trend
Mostly stable
Evidence
Stable or improving margins · 11.6%Positive revenue growth · 6.6%Positive free cash flow · 0.49Reasonable earnings multiple · 20.6Manageable debt level · 0.09
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$4.57
Change0.00%
Shares Out147.80M
Market Cap$675.43M
Enterprise Value$541.09M
52W Range3.03 - 7.97
Beta1.45
P/E108.29
P/S1.90
P/B3.13
P/FCF14.52
EV/Sales1.52

Investment DNA

How strong this company looks for long-term investors

77
out of 100
Business Quality
Margins, moat, returns
75/100
Financial Strength
Debt, cash, stability
95/100
Growth Potential
Revenue and expansion
87/100
Price Attractiveness
Cheap or expensive today
77/100
Why this score▼
Stable or improving margins · 11.6%Positive revenue growth · 6.6%Positive free cash flow · 0.49Reasonable earnings multiple · 20.6Manageable debt level · 0.09Healthy liquidity · 4.32

Analyst view

Analyst sentiment and price target

MDXG
Analyst sentiment
Based on 15 analyst votes · 2026-09-05
83/100
Bullish
Bullish
12
Hold
1
Bearish
2
Price Target
2026-07-31
Low
$7.00
Mean
$8.50
Median
$8.50
High
$10.00

Company Overview

IPO: 2/12/2008
Industry: Biotechnology
P/B i: 3.13
Debt / Equity i: 0.09
Operating Margin: 15.26%
Net Margin: 11.60%
ROE i: -
ROIC: -

Financial Health

Score19 / 20
Debt / Equity: 0.09
Current Ratio: 4.32
Quick Ratio: 3.92
Status: Strong

Insider Transactions

Recent executive and insider activity

DOUG RICE
Transaction: 07/02/2026
SELL
Change
-12,749
Price
$3.95
Filing
07/07/2026
Type
SELL
Maersk-Moller Kimberly
Transaction: 06/24/2026
SELL
Change
-19,820
Price
$3.83
Filing
06/25/2026
Type
SELL
Olson Tiffany
Transaction: 06/10/2026
BUY
Change
+50,913
Price
$3.64
Filing
06/12/2026
Type
BUY